Apogee Therapeutics

0 followers


Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.

Industries

Headquarters

Employees

Links

Org chart

Michael Henderson
Chief Executive Officer at Apogee Therapeutics

Michael Henderson

Collapse
Carl Dambkowski
Chief Medical Officer
Dan Mulreany
Senior Vice President, Business Development and Strategy
Drew Badger
Senior Vice-President, Regulatory Affairs & Toxicology
Emily K Cox
Vp, Head Of People
Jane Pritchett Henderson
Chief Financial Officer
Wendy Aspden-Curran
Senior Vice President, Clinical Operations
Jordan Adajar
Director Of Regulatory Affairs
Mehrak Kiankarimi
Senior Vice President, Operations and Program Management
Kristine Nograles
SVP, Clinical Development
Nimish Shah
Co-Founder and Board Director
Elizabeth W.
Senior Vice President, Quality Assurance
Tim Piringer
Senior Vice President, IT
Lukas Dillinger
Vice President, Research and Translational Medicine
Rebecca Dabora, PhD
Chief Technical Officer